BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Guanabenz Acetate

An alpha-2 selective adrenergic agonist used as an antihypertensive agent.

13+ PubMed studies analyzed · 1 RCTs · Evidence Score: 38

Research Domains

Guanabenz Acetate has been studied across 7 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 🫁 Liver & Detox, 🔬 Oncology, 🧘 Stress & Anxiety. The primary research focus is ❤️ Cardiovascular with 39% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Guanabenz Acetate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

tolterodine
3 shared targets
n
3 shared targets
acetylcholine
2 shared targets
lopinavir
2 shared targets
Cyclizine
2 shared targets
rhinopront
2 shared targets
chlorprothixene
3 shared targets
oxotremorine
2 shared targets
endo
2 shared targets
Chlorpheniramine
2 shared targets
Loading evidence profile...

This evidence profile for Guanabenz Acetate is generated deterministically from 13 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.